National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 7751-7752 [08-585]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 28 / Monday, February 11, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
rwilkins on PROD1PC63 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Competitive Research (Score) Grant
Applications.
Date: March 3, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Arthur L. Zachary, PhD,
Office of Scientific Review, National Institute
of General Medical Sciences, National
Institutes of Health, Natcher Building, Room
3AN–12, Bethesda, MD 20892, (301) 594–
2886, zacharya@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Minority Biomedical Research
Support in Behavior.
Date: March 3, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel and Executive
Meeting Center, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Rebecca H. Johnson, PhD,
Office of Scientific Review, National Institute
of General Medical Sciences, National
Institutes of Health, Natcher Building, Room
3AN18C, Bethesda, MD 20892, (301) 594–
2771, johnsonrh@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Minority Biomedical Research
Support in Chemistry.
Date: March 11–12, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Legacy Hotel and Meeting
Center, 1775 Rockville Pike, Rockville, MD
20852.
Contact Person: Helen R. Sunshine, PhD,
Chief, Office of Scientific Review, National
Institute of General Medical Sciences,
VerDate Aug<31>2005
16:44 Feb 08, 2008
Jkt 214001
National Institutes of Health, Natcher
Building, Room 3AN12F, Bethesda, MD
20892, (301) 594–2881,
sunshinh@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Collaborative Studies on Systems
Biology of Complex Phenotypes.
Date: March 13, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Hotel, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Arthur L. Zachary, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN–12,
Bethesda, MD 20892, (301) 594–2886,
zacharya@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: February 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–583 Filed 2–8–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Biomedical Research and Research
Training Review Subcommittee A.
Date: March 6, 2008.
Time: 8 a.m. to 5 p.m.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
7751
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20817.
Contact Person: Carole H. Latker, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN18,
Bethesda, MD 20892, (301) 594–2848,
latkerc@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: February 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–584 Filed 2–8–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID DMID Clinical
Proteomics Centers for Infectious Diseases
and Biodefense.
Date: March 3–4, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Alec Ritchie, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID/DHHS,
E:\FR\FM\11FEN1.SGM
11FEN1
7752
Federal Register / Vol. 73, No. 28 / Monday, February 11, 2008 / Notices
6700 B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–435–1614,
aritchie@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
NW., Suite 1500N, Washington, DC
20229, 202–344–1060.
Dated: January 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–587 Filed 2–8–08; 8:45 am]
Dated: January 31, 2008.
Ira S. Reese,
Executive Director, Laboratories and
Scientific Services.
[FR Doc. E8–2432 Filed 2–8–08; 8:45 am]
Dated: February, 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–585 Filed 2–8–08; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 9111–14–P
DEPARTMENT OF HOMELAND
SECURITY
DEPARTMENT OF HOMELAND
SECURITY
BILLING CODE 4140–01–M
U.S. Customs and Border Protection
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Accreditation and Approval of
Inspectorate America Corporation, as a
Commercial Gauger and Laboratory
Bureau of Customs and Border
Protection
National Institutes of Health
AGENCY:
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
rwilkins on PROD1PC63 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Outstanding New
Environmental Scientist Award.
Date: March 6–7, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Radisson Governor’s Inn, I–40
at Davis Drive, Exit 280, Research Triangle
Park, NC 27709.
Contact Person: Janice B. Allen, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research and Training, Nat. Institute of
Environmental Health Science, P.O. Box
12233, MD EC–30/Room 3170 B, Research
Triangle Park, NC 27709, 919/541–7556.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
VerDate Aug<31>2005
16:44 Feb 08, 2008
Jkt 214001
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval of Inspectorate America
Corporation, as a commercial gauger
and laboratory.
SUMMARY: Notice is hereby given that,
pursuant to 19 CFR 151.12 and 19 CFR
151.13, Inspectorate America
Corporation, 2 Williams Street, Chelsea,
MA 02150, has been approved to gauge
and accredited to test petroleum and
petroleum products, organic chemicals
and vegetable oils for customs purposes,
in accordance with the provisions of 19
CFR 151.12 and 19 CFR 151.13. Anyone
wishing to employ this entity to conduct
laboratory analyses and gauger services
should request and receive written
assurances from the entity that it is
accredited or approved by the U.S.
Customs and Border Protection to
conduct the specific test or gauger
service requested. Alternatively,
inquiries regarding the specific test or
gauger service this entity is accredited
or approved to perform may be directed
to the U.S. Customs and Border
Protection by calling (202) 344–1060.
The inquiry may also be sent to
cbp.labhq@dhs.gov. Please reference the
Web site listed below for a complete
listing of CBP approved gaugers and
accredited laboratories. https://cbp.gov/
xp/cgov/import/operations_support/
labs_scientific_svcs/
commercial_gaugers/.
DATES: The accreditation and approval
of Inspectorate America Corporation, as
commercial gauger and laboratory
became effective on July 24, 2007. The
next triennial inspection date will be
scheduled for July 2010.
FOR FURTHER INFORMATION CONTACT:
Commercial Gauger Laboratory Program
Manager, Laboratories and Scientific
Services, U.S. Customs and Border
Protection, 1300 Pennsylvania Avenue,
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Notice of Issuance of Final
Determination Concerning MilitaryGrade Flashlight and Replacement Part
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of final determination.
AGENCY:
SUMMARY: This document provides
notice that the Bureau of Customs and
Border Protection (CBP) has issued a
final determination concerning the
country of origin of certain militarygrade flashlights and their replacement
parts to be offered to the United States
Government under an undesignated
government procurement contract.
Based on the facts presented, the final
determination found that the United
States is the country of origin of both
the subject flashlights and their
replacement parts for purposes of U.S.
Government procurement.
DATES: The final determination was
issued on February 5, 2008. A copy of
the final determination is attached. Any
party-at-interest, as defined in 19 CFR
177.22(d), may seek judicial review of
this final determination within 30 days
of February 11, 2008.
FOR FURTHER INFORMATION CONTACT:
Holly Files, Valuation and Special
Programs Branch, Regulations and
Rulings, Office of International Trade
(202–572–8740).
SUPPLEMENTARY INFORMATION: Notice is
hereby given that on February 5, 2008,
pursuant to subpart B of part 177,
Customs Regulations (19 CFR part 177,
subpart B), CBP issued a final
determination concerning the country of
origin of certain military-grade
flashlights and their replacement parts
to be offered to the United States
Government under an undesignated
government procurement contract. The
CBP ruling number is H017620. This
final determination was issued at the
request of Energizer Battery, Inc. under
procedures set forth at 19 CFR part 177,
subpart B, which implements Title III of
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 73, Number 28 (Monday, February 11, 2008)]
[Notices]
[Pages 7751-7752]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-585]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID DMID Clinical Proteomics
Centers for Infectious Diseases and Biodefense.
Date: March 3-4, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Alec Ritchie, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institutes of Health/NIAID/DHHS,
[[Page 7752]]
6700 B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-435-
1614, aritchie@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February, 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-585 Filed 2-8-08; 8:45 am]
BILLING CODE 4140-01-M
